TERMIS 2021 | Supporting start-ups to accelerate biomedical innovations

Multiple start-ups face issues relating to clinical translation of their products due to development process. Kurt Gielen, MedAce, Maastricht, The Netherlands, describes how MedAce collaborates with companies to help them prepare their products for clinical use by providing research and development facilities, as well as regulatory consulting which many smaller companies face. This interview took place at 6th world congress of the Tissue Engineering and Regenerative Medicine International Society (TERMIS 2021).